Estrogen replacement therapy at menopause. How benefits outweigh risks

Area of Science:

• Reproductive medicine
• Endocrinology
• Gerontology

Background:

• Menopause is associated with significant health risks, including bone loss and cardiovascular disease.
• Estrogen deficiency plays a key role in the pathogenesis of these menopausal complications.

Purpose of the Study:

• To evaluate the benefits of early estrogen replacement therapy in postmenopausal women.
• To assess the protective effects of estrogen on bone density and cardiovascular health.
• To discuss the potential risks of estrogen therapy, specifically endometrial and breast cancer.

Main Methods:

• Review of existing scientific literature and clinical studies on estrogen replacement therapy.
• Analysis of data regarding bone mineral density, fracture rates, and cardiovascular events in menopausal women.
• Examination of epidemiological evidence on the incidence of endometrial and breast cancer in relation to estrogen use.

Main Results:

• Estrogen replacement therapy is effective in preventing bone loss and reducing fracture rates in menopausal women.
• Evidence suggests potential cardiovascular protective effects of estrogen replacement therapy.
• Estrogen therapy is associated with an increased risk of endometrial and breast cancer.

Conclusions:

• Early initiation of estrogen replacement therapy is recommended for menopausal women to mitigate bone loss and fracture risk.
• The potential cardiovascular benefits warrant further investigation.
• A careful risk-benefit assessment is crucial, considering the increased risk of certain cancers.